ArticleFrontiers in medicine2022

CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer.

Yichun Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.